The state of South Dakota currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Aberdeen and Watertown.
Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
01/23/2025
Locations: Avera Research Institute, Sioux Falls, South Dakota
Conditions: Idiopathic Pulmonary Fibrosis